The Food and Drug Administration (FDA) has okayed the mail-order dispensation of an abortion-inducing drug. The American Association of Pro-life Obstetricians and Gynecologists (AAPLOG) sees no reason to celebrate. The following statement, including the heading, was published in the AAPLOG email newsletter.
FDA’s reckless decision to allow mail order abortions
This week, the US Food and Drug Administration (FDA) further relaxed the requirements for dispensing the abortion drug Mifeprex. Now women will be able with FDA blessing, to receive Mifeprex through the mail without verifying gestational age, testing for Rh negativity or administering Rhogam, and without ruling out ectopic pregnancy. This would of course be malpractice in real medicine, but is FDA approved for Mifeprex. Why? FDA’s rationale is astounding. They reviewed 4 select admittedly poorly designed studies funded by the abortion industry. And more. According to a letter sent from FDA to ACOG : ” CDER also reviewed postmarketing adverse events that reportedly occurred from January 27, 2020 – January 12, 2021, with mifepristone use for medical termination of early pregnancy, along with available information about deviations or noncompliance events associated with the Mifepristone REMS Program. 2 CDER found that the small number of adverse events reported to FDA during the COVID-19 public health emergency (PHE) provide no indication that any program deviation or noncompliance with the Mifepristone REMS Program contributed to the reported adverse events.” The incredibly irony is that FDA dropped the requirement to report adverse events from Mifeprex (other than death) back in 2016. So no thinking human being would expect any change in adverse event reporting when no adverse event reporting was required at all since 2016!—AAPLOG, December 2021
Christina Francis, MD, chair of the AAPLOG board, released an op-ed about the new FDA policy. Here’s an excerpt (although the statement is well worth reading in full): “…our patients are more than mere statistics. It’s bad enough that preborn patients are chemically starved to death from these medications, but they also pose potential harms to our maternal patients. Abandoning patients to the closest emergency room, which may be several towns away, is not good medicine. I implore the Food and Drug Administration to focus on health care that favors women and children instead of abandoning basic medical standards in the name of ‘reproductive choice’.”